Larvol Delta - APL101-Study-of-Subjects-With-NSCLC-With-cMet-EXON-14-Skip-Mutations-and-cMet-Dysregulation-Advanced-Solid-Tumors

bozitinib (APL-101) - Apollomics

CBT101 - CHA Bio & Diostech

http://clinicaltrials.gov/ct2/show/NCT03175224

Aug 21, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next